Floatz logo

SODIUM CITRATE

Heart Defects, Congenital

National Center for Research Resources (NCRR)mixtureDormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Heart Defects, Congenital cohort.

Asset / SponsorPhaseRating
Dolutegravir
Augusta University
Phase 4BB
Tirzepatide
University Medical Centre Ljubljana
Phase 4BB
Sildenafil
Mayo Clinic
Phase 3B
Fibrinogen Concentrate Human
IRCCS Policlinico S. Donato
Phase 2CCC
Prothrombin Complex Concentrate, Human
IRCCS Policlinico S. Donato
Phase 2CCC

View all 10 →

Same molecule, other indications

SODIUM CITRATE is also rated in:

arthropathyDormant
CC
Indicative ·
43 / 100
View asset →
hypoparathyroidismDormant
D
Indicative ·
30 / 100
View asset →
tetralogy of fallotDormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →